EPA
Sponsors
Solae, LLC, University of East Anglia, CHU de Quebec-Universite Laval, National Science and Technology Council, Taiwan, Tufts University
Conditions
Alzheimer DiseaseCardiovascular DiseaseCardiovascular Physiological PhenomenaDementia DisorderDocosahexaenoic Acid (All-Z Isomer)Eicosapentaenoic AcidEndothelial Nitric Oxide SynthaseHypertriglyceridemia
Early Phase 1
Phase 2
Unknown Phase
Time and Dose Evaluation of Stearidonic Acid (SDA) to Eicosapentaenoic Acid (EPA) in Red Blood Cells
CompletedNCT01038440
Start: 2009-08-31End: 2010-08-31Updated: 2012-06-18
The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity
CompletedNCT01692431
Start: 2012-09-30End: 2013-10-31Updated: 2013-10-16
Phospholipid Hypothesis of Depression: From Molecular Biology, Neuroimaging to Behaviour
CompletedNCT02615405
Start: 2012-08-31End: 2015-01-31Updated: 2015-11-26
Role of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Inflammation and Lipids
CompletedNCT02670382
Start: 2016-03-31End: 2020-10-31Updated: 2021-04-14
Impact of Smoking Information on Concerns About Radon
CompletedNCT03499535
Start: 2015-08-07End: 2016-04-22Updated: 2019-04-19
The Protective Effect of Omega-3 Fatty Acid on Cognitive Function Among Patients With Mild Dementia
CompletedNCT04972643
Start: 2012-09-23End: 2018-09-23Updated: 2021-07-26
Cardiometabolic Properties of Omega-3 Functionalized With Hydroxytyrosol
Active, not recruitingNCT06992323
Start: 2025-02-17End: 2026-12-31Target: 68Updated: 2025-05-28